Electronic Prescribing Tied to Reduction in Adverse Drug Events
AHRQ Stats: Medicare "Super-Utilizer" Patients
"Super-utilizers"—patients who visit an emergency department (ED) four times or more in a year—accounted for 19 percent of ED visits by people on Medicare for urinary tract infections in 2014. (Source: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project Statistical Brief #221: Characteristics of Emergency Department Visits for Super-Utilizers by Payer, 2014.)
- Electronic Prescribing Tied to Reduction in Adverse Drug Events.
- New Highlights From AHRQ’s Patient Safety Network.
- Register Now: March 23 Webinar on Effective Use of Patient Portals.
- AHRQ in the Professional Literature.
Electronic prescribing (e-prescribing), which is intended to ensure that accurate, error-free and understandable prescriptions are sent directly to pharmacies, was found to lower the risks among diabetes patients of experiencing adverse drug events that required emergency department visits or hospitalizations. In an AHRQ-supported article, researchers examined 2011–2013 data for 3.1 million Medicare Part D beneficiaries who were 66 or older and had taken antidiabetes medications for at least 90 days. Their analysis, published in Medical Care, showed 21 adverse drug events per 1,000 beneficiaries who had at least 75 percent of their medications e-prescribed. Beneficiaries with less e-prescribing, meanwhile, had more adverse drug events—with the highest rate, 44 events per 1,000 diabetes patients, occurring for those patients who had 0.1 percent to 24.9 percent of their prescriptions handled electronically. Access the abstract.
AHRQ’s Patient Safety Network (PSNet), which highlights journal publications, books and tools related to patient safety, has featured a new set of articles including:
- Opioid-prescribing patterns of emergency physicians and risk of long-term use.
- Use of unsolicited patient observations to identify surgeons with increased risk for postoperative complications.
- From board to bedside: how the application of financial structures to safety and quality can drive accountability in a large health care system.
Registration is open for an AHRQ webinar on March 23 from 2:30 to 4 p.m. ET to discuss the effective design and use of patient portals for improving patient care. Presenters will discuss lessons learned from the use of patient portals, including their impact on patient engagement, diabetes self-management and health care quality. Earn 1.5 hours of free CME/CE credits for participating.
Parental perception of built environment characteristics and built environment use among Latino families: a cross-sectional study. Heerman WJ, Mitchell SJ, Thompson J, et al. BMC Public Health 2016 Nov 22;16(1):1180. Access the abstract on PubMed®.
Changes in physician practice patterns after implementation of a communication-and-resolution program. Helmchen LA, Lambert BL, McDonald TB. Health Serv Res 2016 Dec;51 Suppl 3:2516-36. Access the abstract on PubMed®.
Anticoagulation use and clinical outcomes after major bleeding on dabigatran or warfarin in atrial fibrillation. Hernandez I, Zhang Y, Brooks MM, et al. Stroke 2017 Jan;48(1):159-66. Epub 2016 Dec 1. Access the abstract on PubMed®.
Understanding patient, provider, and system factors related to Medicaid readmissions. Jiang HJ, Boutwell AE, Maxwell J, et al. Jt Comm J Qual Patient Saf. 2016 Mar;42(3):115-21. Access the abstract on PubMed®.
Measuring mortality performance: how did safety-net hospitals compare with other hospitals? Jiang HJ, Reiter KL, Wang J. Med Care 2016 Jul;54(7):648-56. Access the abstract on PubMed®.
Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. Kavalieratos D, Corbelli J, Zhang D, et al. JAMA 2016 Nov 22;316(20):2104-14. Access the abstract on PubMed®.
Chronic condition clusters and functional impairment in older cancer survivors: a population-based study. Kenzik KM, Kent EE, Martin MY, et al. J Cancer Surviv 2016 Dec;10(6):1096-1103. Epub 2016 May 27. Access the abstract on PubMed®.
Switching generic antiepileptic drug manufacturer not linked to seizures: a case-crossover study. Kesselheim AS, Bykov K, Gagne JJ, et al. Neurology 2016 Oct 25;87(17):1796-1801. Epub 2016 Sep 28. Access the abstract on PubMed®.
Please address comments and questions regarding the AHRQ Electronic Newsletter to Bruce Seeman at firstname.lastname@example.org or 301-427-1998.
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in.
If you have any questions or problems with the subscription service, email: email@example.com. For other inquiries, Contact Us.
This service is provided to you at no charge by the Agency for Healthcare Research and Quality (AHRQ).
Page originally created March 2017